Biotech Approvals and Earnings Signals Lift Hong Kong Small-Cap Sentiment

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Innovent Biologics (2922.HK) received National Medical Products Administration approval for its cholesterol treatment IBI306 last month, marking a key milestone for the biotech sector. Hua Hong Semiconductor (1473.HK) concurrently announced plans for a new 12-inch wafer fabrication facility in Shanghai, targeting 2027 completion. China Taiping Insurance (2601.HK) reported 12% year-on-year profit growth in Q1 2026, driven by stronger investment returns. New Oriental Education & Technology (8375.HK) saw its live-stream e-commerce GMV rise 30% month-on-month in May. COSCO Shipping International (1119.HK) recorded 8% year-over-year growth in container volume, while Taiho Holdings (1617.HK) narrowed losses through property sales recovery. Tin Chan Holdings (6896.HK) secured a 新能源 battery materials supply deal, Yingli Green Energy (1579.HK) obtained FDA certification for an active pharmaceutical ingredient, and China Foods Limited (0751.HK) partnered with an international beverage brand. These developments across diverse sectors suggest improving resilience among Hong Kong's smaller listed companies.

Source: Global Report The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.